These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 39053214
1. The influence of COVID-19 on attention-deficit/hyperactivity disorder diagnosis and treatment rates across age, gender, and socioeconomic status: A 20-year national cohort study. Shkalim Zemer V, Manor I, Weizman A, Cohen HA, Hoshen M, Menkes Caspi N, Cohen S, Faraone SV, Shahar N. Psychiatry Res; 2024 Sep; 339():116077. PubMed ID: 39053214 [Abstract] [Full Text] [Related]
2. U.S. national, regional, and state-specific socioeconomic factors correlate with child and adolescent ADHD diagnoses pre-COVID-19 pandemic. Bozinovic K, McLamb F, O'Connell K, Olander N, Feng Z, Haagensen S, Bozinovic G. Sci Rep; 2021 Nov 10; 11(1):22008. PubMed ID: 34759326 [Abstract] [Full Text] [Related]
3. Attention-Deficit/Hyperactivity Disorder Diagnoses in Finland During the COVID-19 Pandemic. Auro K, Holopainen I, Perola M, Havulinna AS, Raevuori A. JAMA Netw Open; 2024 Jun 03; 7(6):e2418204. PubMed ID: 38935377 [Abstract] [Full Text] [Related]
4. The impact of the COVID-19 pandemic on children and young people. Magklara K, Kyriakopoulos M. Psychiatriki; 2023 Dec 29; 34(4):265-268. PubMed ID: 37982248 [Abstract] [Full Text] [Related]
5. Primary Care Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in School-Age Children: Trends and Disparities During the COVID-19 Pandemic. Bannett Y, Dahlen A, Huffman LC, Feldman HM. J Dev Behav Pediatr; 2022 Sep 01; 43(7):386-392. PubMed ID: 35503665 [Abstract] [Full Text] [Related]
6. Home participation, support and barriers among children with attention-deficit/hyperactivity disorder before and during the COVID-19 pandemic. Kaya Kara O, Tonak HA, Kara K, Sonbahar Ulu H, Kose B, Sahin S, Kara MZ. Public Health; 2021 Jul 01; 196():101-106. PubMed ID: 34171615 [Abstract] [Full Text] [Related]
7. [Attention deficit hyperactivity disorder in children and adolescents: lessons from the COVID-19 pandemic]. Chutko LS, Fateeva VV, Surushkina SY. Zh Nevrol Psikhiatr Im S S Korsakova; 2024 Jul 01; 124(1):60-65. PubMed ID: 38261285 [Abstract] [Full Text] [Related]
8. [How do children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) experience lockdown during the COVID-19 outbreak?]. Bobo E, Lin L, Acquaviva E, Caci H, Franc N, Gamon L, Picot MC, Pupier F, Speranza M, Falissard B, Purper-Ouakil D. Encephale; 2020 Jun 01; 46(3S):S85-S92. PubMed ID: 32522407 [Abstract] [Full Text] [Related]
9. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups. Chung W, Jiang SF, Paksarian D, Nikolaidis A, Castellanos FX, Merikangas KR, Milham MP. JAMA Netw Open; 2019 Nov 01; 2(11):e1914344. PubMed ID: 31675080 [Abstract] [Full Text] [Related]
10. How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Huss M, Hölling H, Kurth BM, Schlack R. Eur Child Adolesc Psychiatry; 2008 Dec 01; 17 Suppl 1():52-8. PubMed ID: 19132304 [Abstract] [Full Text] [Related]
11. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample. Caye A, Agnew-Blais J, Arseneault L, Gonçalves H, Kieling C, Langley K, Menezes AMB, Moffitt TE, Passos IC, Rocha TB, Sibley MH, Swanson JM, Thapar A, Wehrmeister F, Rohde LA. Epidemiol Psychiatr Sci; 2019 May 15; 29():e37. PubMed ID: 31088588 [Abstract] [Full Text] [Related]
12. Experiences of children and young people with attention deficit hyperactivity disorder (ADHD) during COVID-19 pandemic and lockdown restrictions. Bailie V, Linden MA. Disabil Rehabil; 2024 Feb 15; 46(3):489-496. PubMed ID: 36617961 [Abstract] [Full Text] [Related]
13. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF, Miller A, Fine S. Pediatrics; 2004 Nov 15; 114(5):e541-7. PubMed ID: 15520087 [Abstract] [Full Text] [Related]
14. Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016. Xu G, Strathearn L, Liu B, Yang B, Bao W. JAMA Netw Open; 2018 Aug 03; 1(4):e181471. PubMed ID: 30646132 [Abstract] [Full Text] [Related]
15. Challenges of children and adolescents with attention-deficit/hyperactivity disorder during the COVID-19 pandemic. Kuygun Karci C, Arici Gurbuz A. Nord J Psychiatry; 2022 Jul 03; 76(5):372-379. PubMed ID: 34586933 [Abstract] [Full Text] [Related]
16. Remote Learning During COVID-19: Examining School Practices, Service Continuation, and Difficulties for Adolescents With and Without Attention-Deficit/Hyperactivity Disorder. Becker SP, Breaux R, Cusick CN, Dvorsky MR, Marsh NP, Sciberras E, Langberg JM. J Adolesc Health; 2020 Dec 03; 67(6):769-777. PubMed ID: 33069580 [Abstract] [Full Text] [Related]
17. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. JAMA; 1998 Apr 08; 279(14):1100-7. PubMed ID: 9546570 [Abstract] [Full Text] [Related]
18. Caregivers' Difficulty in Managing Smartphone Use of Children with Attention-Deficit/Hyperactivity Disorder during the COVID-19 Pandemic: Relationships with Caregiver and Children Factors. Lee JI, Hsiao RC, Tsai CS, Yen CF. Int J Environ Res Public Health; 2022 Apr 25; 19(9):. PubMed ID: 35564588 [Abstract] [Full Text] [Related]
19. Associations Between Anxiety and Home Learning Difficulties in Children and Adolescents with ADHD During the COVID-19 Pandemic. Jackson A, Melvin GA, Mulraney M, Becker SP, Bellgrove MA, Quach J, Hutchinson D, Westrupp EM, Montgomery A, Sciberras E. Child Psychiatry Hum Dev; 2023 Oct 25; 54(5):1347-1359. PubMed ID: 35290556 [Abstract] [Full Text] [Related]
20. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study. Dalsgaard S, Nielsen HS, Simonsen M. J Child Adolesc Psychopharmacol; 2013 Sep 25; 23(7):432-9. PubMed ID: 24015896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]